Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 2/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.34 |
| ▸ | DPP4 | P27487 | 2/20 | 0.33 |
| ▸ | IDO1 | P14902 | 2/20 | 0.31 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.31 |
| ▸ | AOC1 | P19801 | 1/20 | 0.30 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28936286 | 0.84 | MAPT (0.37) | OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL2111676 | 0.82 | IDO1 (0.35) | IDO1 | |
| SCHEMBL29393805 | 0.82 | NPBWR1 (0.33) | — | |
| SCHEMBL139764 | 0.82 | NPBWR1 (0.33) | — | |
| SCHEMBL139734 | 0.80 | GABRA1 (0.36) | IDO1 | |
| SCHEMBL9480548 | 0.80 | CHRM2 (0.45) | — | |
| SCHEMBL1492149 | 0.79 | ATM (0.35) | — | |
| SCHEMBL10772792 | 0.76 | ALDH1A1 (0.39) | IDO1 | |
| SCHEMBL28350065 | 0.75 | L3MBTL1 (0.37) | — | |
| SCHEMBL394900 | 0.74 | GABRA1 (0.44) | PNMTTAAR1DPP4OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150185512-A1 | LIQUID-CRYSTAL DISPLAY ELEMENT AND SUBSTRATE USED IN SAME | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2015-07-02 | — | — | US | disclosed |
| US-20130021546-A1 | LIQUID-CRYSTAL DISPLAY ELEMENT AND SUBSTRATE USED IN SAME | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2013-01-24 | — | — | US | disclosed |
| EP-1764118-B1 | Polymer coating for medical devices | GILEAD PALO ALTO INC (US) | 2010-08-25 | — | — | EP | disclosed |
| EP-1937328-B1 | POLYMER COATING FOR MEDICAL DEVICES | CV THERAPEUTICS INC (US) | 2009-08-26 | — | — | EP | disclosed |
| US-7419709-B2 | Polymer coating for medical devices | CV THERAPEUTICS, INC. (US) | 2008-09-02 | — | — | US | disclosed |
| US-20080160166-A1 | POLYMER COATING FOR MEDICAL DEVICES | RYPACEK FRANTISEK | 2008-07-03 | — | — | US | disclosed |
| EP-1937328-A1 | POLYMER COATING FOR MEDICAL DEVICES | CV THERAPEUTICS, INC. (US) | 2008-07-02 | — | — | EP | disclosed |
| US-7364768-B2 | Polymer coating for medical devices | CV THERAPEUTICS, INC. (US) | 2008-04-29 | — | — | US | disclosed |
| WO-2007041972-A1 | POLYMER COATING FOR MEDICAL DEVICES | CV THERAPEUTICS, INC. (US) | 2007-04-19 | — | — | WO | disclosed |
| US-20070071926-A1 | Polymer coating for medical devices | RYPACEK FRANTISEK | 2007-03-29 | — | — | US | disclosed |
| EP-1764118-A2 | Polymer coating for medical devices | CV THERAPEUTICS, INC. (US) | 2007-03-21 | — | — | EP | disclosed |
| US-7160592-B2 | Polymer coating for medical devices | CV THERAPEUTICS, INC. (US) | 2007-01-09 | — | — | US | disclosed |
| EP-1492581-B1 | POLYMER COATING FOR MEDICAL DEVICES | CV THERAPEUTICS INC (US) | 2006-12-20 | — | — | EP | disclosed |
| US-20060093771-A1 | Polymer coating for medical devices | CV THERAPEUTICS, INC. | 2006-05-04 | — | — | US | disclosed |
| EP-1492581-A1 | POLYMER COATING FOR MEDICAL DEVICES | CV THERAPEUTICS, INC. (US) | 2005-01-05 | — | — | EP | disclosed |
| US-20030219562-A1 | Polymer coating for medical devices | CV THERAPEUTICS, INC. | 2003-11-27 | — | — | US | disclosed |
| WO-2003068289-A1 | POLYMER COATING FOR MEDICAL DEVICES | CV THERAPEUTICS, INC. (US) | 2003-08-21 | — | — | WO | disclosed |
| EP-0980895-A1 | HIGH-MOLECULAR ALIPHATIC POLYESTER RESIN COMPOSITION | Showa Denko Kabushiki Kaisha (JP) | 2000-02-23 | — | — | EP | disclosed |
| US-4863831-A | Photosensitive lithographic plate requiring no dampening water having a gelatin primer layer | FUJI PHOTO FILM CO., LTD. (JP) | 1989-09-05 | — | — | US | disclosed |
| US-4861698-A | HARDENED GELATIN, SILICONE RUBBER | FUJI PHOTO FILM CO., LTD. (JP) | 1989-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130021546-A1 | LIQUID-CRYSTAL DISPLAY ELEMENT AND SUBSTRATE USED IN SAME | ZKSCAN2, L1CAM, SDC2 | PNMT 4344/4885TAAR1 3101/4885DPP4 3210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.